Suchergebnisse - "Cottin, Vincent"

PubPharm (30)

1

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)

enthalten in: BMJ open respiratory research | 2023

von Maher, T. | Assassi, S. | Azuma, A. | +12

2

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)

enthalten in: BMJ open respiratory research | 2023

von Richeldi, L. | Azuma, A. | Cottin, V. | +10

3

Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD) : a double-blind, randomised, placebo-controlled trial

enthalten in: The European respiratory journal | 2023

von Mankikian, J. | Caille, A. | Reynaud-Gaubert, M. | +31

CommentIn: Eur Respir J. 2023 Jun 8;61(6):. - PMID 37290812

4

GLPG1205 for idiopathic pulmonary fibrosis : a phase 2 randomised placebo-controlled trial

enthalten in: The European respiratory journal | 2023

von Strambu, I. | Seemayer, C. | Fagard, L. | +10

CommentIn: Eur Respir J. 2023 Mar 2;61(3):. - PMID 36863732

5

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis

enthalten in: BMJ open respiratory research | 2022

von Nathan, S. | Behr, J. | Cottin, V. | +7

6

Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

enthalten in: The New England journal of medicine | 2022

von Richeldi, L. | Azuma, A. | Cottin, V. | +107

CommentIn: N Engl J Med. 2022 Jun 9;386(23):2235-2236. - PMID 35675182

7

Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases : data from the randomized controlled INBUILD trial

enthalten in: Respiratory research | 2022

von Cottin, V. | Martinez, F. | Jenkins, R. | +7

8

Nintedanib in progressive interstitial lung diseases : data from the whole INBUILD trial

enthalten in: The European respiratory journal | 2022

von Flaherty, K. | Wells, A. | Cottin, V. | +12

9

Pirfenidone in Unclassifiable Interstitial Lung Disease : A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use

enthalten in: Advances in therapy | 2022

von Kreuter, M. | Maher, T. | Corte, T. | +5

10

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Naccache, J. | Jouneau, S. | Didier, M. | +49

CommentIn: Lancet Respir Med. 2022 Jan;10(1):e3. - PMID 34973212